Published in Arterioscler Thromb Vasc Biol on November 01, 1999
Atheroprotective effects of neuronal nitric oxide synthase in apolipoprotein e knockout mice. Arterioscler Thromb Vasc Biol (2006) 1.58
The atherogenic effect of excess methionine intake. Proc Natl Acad Sci U S A (2003) 1.35
Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis (2011) 1.22
Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J Physiol (2003) 1.09
Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse. J Biomed Sci (2012) 0.99
Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. Br J Pharmacol (2003) 0.97
Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models. Curr Drug Targets (2008) 0.92
The effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youth. Diabetes (2013) 0.92
Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/-apolipoprotein E-/- mice. Arterioscler Thromb Vasc Biol (2003) 0.86
Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases. Future Lipidol (2008) 0.83
Vinpocetine attenuates lipid accumulation and atherosclerosis formation. Biochem Biophys Res Commun (2013) 0.81
Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouse. Redox Biol (2013) 0.81
Endothelium-dependent relaxations in the aorta from K(2p)6.1 knockout mice. Am J Physiol Regul Integr Comp Physiol (2013) 0.77
Atherosclerosis differentially affects calcium signalling in endothelial cells from aortic arch and thoracic aorta in Apolipoprotein E knockout mice. Physiol Rep (2014) 0.76
Effects of mechanical properties and atherosclerotic artery size on biomechanical plaque disruption - mouse vs. human. J Biomech (2014) 0.75
The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice. Vascul Pharmacol (2015) 0.75
Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. Mediators Inflamm (2016) 0.75
Integrating functional genomic information into the Saccharomyces genome database. Nucleic Acids Res (2000) 18.52
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (1996) 16.92
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (1976) 13.19
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut (2009) 8.98
The Stanford Microarray Database. Nucleic Acids Res (2001) 7.77
Genome-wide expression profiling in Escherichia coli K-12. Nucleic Acids Res (1999) 7.20
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins (1976) 4.54
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins (1976) 4.44
Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med (1998) 4.16
Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins (1977) 3.80
Towards functional characterisation of the members of the R2R3-MYB gene family from Arabidopsis thaliana. Plant J (1998) 3.75
The chemical structure of prostaglandin X (prostacyclin). Prostaglandins (1976) 3.63
The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol (1990) 3.57
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55
Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron (1995) 3.37
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest (1994) 3.11
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med (1999) 3.07
Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature (1976) 2.83
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A (2001) 2.77
Saccharomyces Genome Database provides tools to survey gene expression and functional analysis data. Nucleic Acids Res (2001) 2.71
Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48
A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med (1998) 2.43
A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins (1976) 2.28
Function search in a large transcription factor gene family in Arabidopsis: assessing the potential of reverse genetics to identify insertional mutations in R2R3 MYB genes. Plant Cell (1999) 2.23
Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron (1995) 2.19
Transcription of a recombinant bunyavirus RNA template by transiently expressed bunyavirus proteins. Virology (1995) 2.13
Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation (1995) 2.07
The effects of prostagladin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations [proceedings]. Br J Pharmacol (1976) 2.06
The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res (2001) 2.03
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92
Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes (1996) 1.85
Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood (2001) 1.73
Human papillomavirus (HPV) infection in seborrheic keratosis. Am J Dermatopathol (1989) 1.71
Codon bias at the 3'-side of the initiation codon is correlated with translation initiation efficiency in Escherichia coli. Gene (2001) 1.65
Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic. Thromb Haemost (2001) 1.64
Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood (1994) 1.64
Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol (1996) 1.63
Prostacyclin is a circulating hormone. Nature (1978) 1.60
The TGF-beta signaling pathway is essential for Drosophila oogenesis. Development (1996) 1.58
Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation (1999) 1.58
Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol (2006) 1.58
Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition. Prostaglandins (1976) 1.56
Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci U S A (1990) 1.55
Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J Immunol (2000) 1.52
Somatotroph and lactotroph changes in the adenohypophyses of mice with disrupted insulin-like growth factor I gene. Endocrinology (1999) 1.52
Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation (1995) 1.51
Gene expression analysis by transcript profiling coupled to a gene database query. Nat Biotechnol (1999) 1.50
Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation (1991) 1.44
Effect of multiple mutations in the hemoglobin- and hemoglobin-haptoglobin-binding proteins, HgpA, HgpB, and HgpC, of Haemophilus influenzae type b. Infect Immun (1999) 1.41
Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis. Prostaglandins (1976) 1.40
Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM. Oncogene (2008) 1.38
The regulation of blood vessel growth by vascular endothelial growth factor. Ann N Y Acad Sci (1995) 1.34
Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am J Physiol Lung Cell Mol Physiol (2001) 1.33
The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores. Virology (1997) 1.31
Effects of intravenous infusion of prostacyclin (PGI2) in man. Prostaglandins (1980) 1.30
The involvement of ankyrin in the regulation of inositol 1,4,5-trisphosphate receptor-mediated internal Ca2+ release from Ca2+ storage vesicles in mouse T-lymphoma cells. J Biol Chem (1993) 1.30
Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors. J Mol Biol (2008) 1.30
Inhibition of phospholipase C dependent processes by U-73, 122. Adv Prostaglandin Thromboxane Leukot Res (1989) 1.27
hgpB, a gene encoding a second Haemophilus influenzae hemoglobin- and hemoglobin-haptoglobin-binding protein. Infect Immun (1998) 1.26
Nucleotide sequence analysis shows that Rhopalosiphum padi virus is a member of a novel group of insect-infecting RNA viruses. Virology (1998) 1.26
A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature (1992) 1.26
Human neuronal gamma-aminobutyric acid(A) receptors: coordinated subunit mRNA expression and functional correlates in individual dentate granule cells. J Neurosci (1999) 1.24
Cross-cultural studies of dementia. A comparison of mini-mental state examination performance in Finland and China. Arch Neurol (1989) 1.23
Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol (1994) 1.22
Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther (2007) 1.22
Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation (1994) 1.21
Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation (1997) 1.21
Antiviral properties of a series of 1,6-naphthyridine and 7, 8-dihydroisoquinoline derivatives exhibiting potent activity against human cytomegalovirus. Antimicrob Agents Chemother (2000) 1.20
Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clin Invest (1996) 1.20
The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications. Br Med Bull (1983) 1.20
A monoclonal antibody that inhibits mouse tissue factor function. J Thromb Haemost (2005) 1.19
Metabolism of leukotriene A4 by human erythrocytes. A novel cellular source of leukotriene B4. J Biol Chem (1984) 1.18
Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology (1999) 1.17
Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol (2000) 1.17
Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle. Proc Natl Acad Sci U S A (1999) 1.17
Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viability. J Virol (2001) 1.16
Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease. Bioorg Med Chem Lett (1998) 1.16
Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man. Br J Clin Pharmacol (1979) 1.16
The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors. Bioorg Med Chem Lett (2000) 1.16
Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am J Physiol (1996) 1.14
Dimensionality-controlled insulator-metal transition and correlated metallic state in 5d transition metal oxides Sr n+1Ir nO3n+1 (n=1, 2, and infinity). Phys Rev Lett (2008) 1.13
Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr Opin Nephrol Hypertens (1996) 1.12
Biochemical and morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition. J Neurosci (1998) 1.12
Mouse models for BRAF-induced cancers. Biochem Soc Trans (2007) 1.11
Mesenchymal hamartoma of the liver: report of an adult case and review of the literature. Intern Med (1992) 1.11
Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. Br J Cancer (2008) 1.11
Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the itpa gene. J Biol Chem (2001) 1.10
Cyclic RGD peptide analogues as antiplatelet antithrombotics. J Med Chem (1992) 1.10
gamma-Aminobutyric acid(A) receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development. J Neurochem (2001) 1.10
Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation (2000) 1.09
Synthesis and structure of the platelet aggregation factor thromboxane A2. Nature (1985) 1.09
X-ray spectroscopy of nitrile hydratase at pH 7 and 9. Biochemistry (1996) 1.09
[Isolation and identification of Leclercia adecarboxylate in clinical isolates in China]. Wei Sheng Wu Xue Bao (1992) 1.09
An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis. J Pathol (2007) 1.09
Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity (1994) 1.09
Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg (1995) 1.08
Construction of a BAC library of Korean ginseng and initial analysis of BAC-end sequences. Mol Genet Genomics (2004) 1.08